Pentax Medical Company Agrees to Pay $43 Million to Resolve Criminal Investigation Concerning Misbranded Endoscopes
Date of publication: 08-04-2020
FDA OCI, Pentax Medical, medical device, misbranded, endoscope, $43 million, criminal charges, revised cleaning instructions, FDA-cleared, reports, timely, drug-resistant bacteria, deferred prosecution agreement, DPA, Źródło: http://www.fda.gov
